Albemarle (ALB) Investor presentation summary

Strategic direction and competitive strengths

• Focus on transforming essential resources into critical ingredients for mobility, energy, connectivity, and health, with a commitment to sustainability and resilience.

• Emphasis on world-class resources, process chemistry expertise, high-impact innovation, and customer-centricity to maintain a leading market position.

• Global footprint spans over 70 countries with more than 7,800 employees and 25+ production and R&D facilities.

• Strategic framework prioritizes purpose-driven growth, stakeholder value, and responsible stewardship.

• Six core values guide operations: care, humility, curiosity, accountability, collaboration, and integrity.

Financial performance and capital allocation

• FY 2025 net sales reached $5.1B with an adjusted EBITDA margin of 21%; total assets at $16B.

• Q1 2026 net sales were $1.4B, with adjusted EBITDA of $664M (up 148% Y/Y) and free cash flow of $248M.

• FY 2025 capex reduced by 65% Y/Y to $590M; FY 2026E capex targeted at $550-600M, focusing on high-return projects.

• Over $2.0B in fresh capital raised, with significant deleveraging actions reducing net debt to EBITDA ratio to 1.0x and annual interest expense by ~$60M.

• Achieved positive FY 2025 free cash flow of $692M and announced asset sales with expected pre-tax proceeds of $660M.

Operational excellence and cost management

• Delivered $450M in cost and productivity improvements since early 2024, with a target of $100-150M in FY 2026.

• Streamlined organizational structure and optimized conversion network, including idling and ramping facilities as needed.

• Operating cash flow conversion trending toward long-term target range of 60-70%.

• Proactive capital discipline and focus on sustaining and productivity investments.